MedShift Releases Important Research and Results That Will Change Vaginal Health Empowerment

Tuesday, October 23, 2018 Women Health News
Email Print This Page Comment bookmark
Font : A-A+

MedShift's $10 million investment has sparked important efforts in brand awareness and research with thousands of patients and doctors; results are critical to the future of women's health

CHARLOTTE, N.C., Oct. 23, 2018 /PRNewswire/ -- After 18 months of research which included thousands of responses to a

clinical study from partner patients and doctors, MedShift is releasing important information which proves what the company has known to be true for years – vConfidence not only delivers results that last, but also serves as the modern woman's trusted partner in vaginal health empowerment.

The research process was comprehensive and precise utilizing defined question from multiple leading clinical studies for incontinence, sexual function, and dryness. MedShift relied heavily on not only data, but also personal feedback from patients and doctors. It included a variety of vConfidence devices and non-invasive procedures; it was distributed to patients who were treated for at least one symptom which included (but was not limited to) urine leakage, dryness or pain during intercourse, or vaginal infections.

Research and results were overwhelmingly positive. Leading the way was this news – of survey respondents who had undergone a single treatment with a vConfidence device, 98.8% experienced overall improvements of symptoms.

"As a certified vConfidence practitioner, I'm excited to see positive results that overwhelmingly prove how much these treatments are improving the quality of life for women," said Dr. Merrill Matschke board certified in Urology specializing in Pelvic Floor Surgery and resolving symptoms of incontinence. 

Other positive highlights include:

  • Among women who had three treatments, only 1.2% reported no improvement in any symptoms
  • Of 140 patients treated for incontinence, 94.67% reported improvements in symptoms post-procedure
  • 93.93% of respondents experienced improvement in their incontinence symptoms after one treatment
  • 91% of respondents reported less painful intercourse and vaginal dryness after one treatment

This research is part of a continued investment by MedShift in women's health. Since its founding, MedShift has invested over $10,000,000 in vConfidence to improve and enhance not only a woman's health issues and concerns, but also how she experiences her life daily. As a result, vConfidence approved practitioners have served thousands of women across North America with safe, non-invasive, energy-based procedures and treatments.

Part of that investment has also included raising brand awareness. In August 2018, the company launched a rebrand designed to make information about these procedures and treatments more accessible - and more real. The new tagline – Why be PC when you can be VC? – started much-needed conversations among women when it comes to their vaginal health - conversations often whispered about or simply Googled.

"MedShift has made a powerful and unprecedented investment in women and women's health," says Dr. Tess Mauricio, Board Certified Dermatologist, fellow of the American Academy of Dermatology, graduate of Stanford University School of Medicine. "That level of commitment, information and resources will empower more women to make a long-term plan for their optimum health and wellness. Imagine what's possible for the future of women's health then."

Cision View original content:


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store